The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunomodulatory switch maintenance therapy in metastatic colorectal carcinoma: The phase III IMPALA study.
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Werner Scheithauer
No Relationships to Disclose
 
Alfredo Zurlo
Employment - MOLOGEN
Leadership - MOLOGEN
 
Ramon Salazar
Consulting or Advisory Role - Amgen; Merck Serono
Speakers' Bureau - Amgen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Merck; Novartis; Roche
 
Michel Ducreux
No Relationships to Disclose
 
Tom Samuel Waddell
No Relationships to Disclose
 
Christophe Tournigand
No Relationships to Disclose
 
Alberto F. Sobrero
No Relationships to Disclose
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Dirk Arnold
No Relationships to Disclose